LYTIR

Insider · SEC Form 4 · Chief Executive Officer

Kroeger Christopher A.

In the 12 months to Nov 8, 2026, on the open market: sold $6.0M of MPLT. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $6.0M in total.Jul: Insider sales $5.4MOct: Insider sales $595KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $6.0M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. MPLTSold: MapLight Therapeutics, Inc. Oct 15, 2026 73,691 shares filed Oct 16, 2026 1,195,909 shares held directly after, as filed filing $595K
  2. MPLTSold: MapLight Therapeutics, Inc. Jul 17, 2026 16,779 shares filed Jul 17, 2026 1,246,455 shares held directly after, as filed filing $636K
  3. MPLTSold: MapLight Therapeutics, Inc. Jul 16, 2026 69,082 shares filed Jul 17, 2026 3 transactions filing $2.5M
  4. MPLTSold: MapLight Therapeutics, Inc. Jul 15, 2026 61,778 shares filed Jul 17, 2026 3 transactions filing $2.3M

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.

Other Form 4 entries

Not counted above: entries this filer reported on Form 4 in the same 12 months that are not open-market purchases or sales. Each entry is one line of a filing.

  • MPLT: grant or award (code A), 1 entry, Aug 17, 2026
Code A
A grant or award from the company, such as stock given as pay.

Source: the same SEC Form 4 filings. The codes are the SEC's own transaction codes; the meanings above are a plain-words reading of the SEC's Form 4 instructions.